RTI International, E. Cornwallis Rd, PO Box 12194, Research Triangle Park, NC, 27709-2194, USA.
University of Washington, Seattle, WA, USA.
Prev Sci. 2023 Oct;24(Suppl 1):50-60. doi: 10.1007/s11121-022-01400-5. Epub 2022 Aug 10.
The rapid rise in opioid misuse, disorder, and opioid-involved deaths among older adolescents and young adults is an urgent public health problem. Prevention is a vital part of the nation's response to the opioid crisis, yet preventive interventions for those at risk for opioid misuse and opioid use disorder are scarce. In 2019, the National Institutes of Health (NIH) launched the Preventing Opioid Use Disorder in Older Adolescents and Young Adults cooperative as part of its broader Helping to End Addiction Long-term (HEAL) Initiative ( https://heal.nih.gov/ ). The HEAL Prevention Cooperative (HPC) includes ten research projects funded with the goal of developing effective prevention interventions across various settings (e.g., community, health care, juvenile justice, school) for older adolescent and young adults at risk for opioid misuse and opioid use disorder (OUD). An important component of the HPC is the inclusion of an economic evaluation by nine of these research projects that will provide information on the costs, cost-effectiveness, and sustainability of these interventions. The HPC economic evaluation is integrated into each research project's overall design with start-up costs and ongoing delivery costs collected prospectively using an activity-based costing approach. The primary objectives of the economic evaluation are to estimate the intervention implementation costs to providers, estimate the cost-effectiveness of each intervention for reducing opioid misuse initiation and escalation among youth, and use simulation modeling to estimate the budget impact of broader implementation of the interventions within the various settings over multiple years. The HPC offers an extraordinary opportunity to generate economic evidence for substance use prevention programming, providing policy makers and providers with critical information on the investments needed to start-up prevention interventions, as well as the cost-effectiveness of these interventions relative to alternatives. These data will help demonstrate the valuable role that prevention can play in combating the opioid crisis.
阿片类药物滥用、障碍和阿片类药物相关死亡在青少年和年轻人中的迅速上升是一个紧迫的公共卫生问题。预防是国家应对阿片类药物危机的重要组成部分,但针对阿片类药物滥用和阿片类药物使用障碍风险人群的预防干预措施却很少。2019 年,美国国立卫生研究院(NIH)启动了预防青少年和年轻人中阿片类药物使用障碍合作研究计划,作为其更广泛的帮助结束成瘾长期(HEAL)倡议的一部分(https://heal.nih.gov/)。HEAL 预防合作研究计划(HPC)包括 10 个研究项目,旨在为处于阿片类药物滥用和阿片类药物使用障碍(OUD)风险的青少年和年轻人在各种环境(如社区、医疗保健、青少年司法、学校)中开发有效的预防干预措施。HPC 的一个重要组成部分是其中 9 个研究项目纳入了经济评估,该评估将提供有关这些干预措施的成本、成本效益和可持续性的信息。HPC 经济评估纳入了每个研究项目的总体设计,通过使用基于活动的成本核算方法前瞻性地收集启动成本和持续交付成本。经济评估的主要目标是估计向提供者提供干预措施的实施成本,估计每项干预措施减少青少年中阿片类药物滥用开始和升级的成本效益,并使用模拟建模来估计在多年内,在各种环境中更广泛地实施这些干预措施的预算影响。HPC 为药物使用预防计划提供了生成经济证据的绝佳机会,为政策制定者和提供者提供了有关启动预防干预措施所需投资的关键信息,以及这些干预措施相对于替代方案的成本效益。这些数据将有助于证明预防在应对阿片类药物危机方面可以发挥的重要作用。